Vaccination of SARS-CoV-2 convalescent individuals generates broad and potent antibody responses. This study isolated 459 spike-specific monoclonal antibodies (mAbs) from two individuals previously infected with SARS-CoV-2 and later boosted with mRNA-1273. The mAbs demonstrated a broad range of immunoglobulin heavy chain (IGH) V genes and neutralizing activity against various SARS-CoV-2 variants. Longitudinal analysis revealed extensive evolution of spike-binding antibodies from acute infection to vaccination five months later, highlighting the efficient recall of affinity-matured memory B cells by vaccination, leading to potent antibody responses in convalescent individuals.
Publisher
Nature Communications
Published On
Apr 19, 2023
Authors
Mark Chernychev, Mrunal Sakharkar, Ruth I. Connor, Haley L. Dugan, Daniel J. Sheward, C. G. Rappazzo, Aron Ståhlmarck, Mattias N. E. Forsell, Peter F. Wright, Martin Corcoran, Ben Murrell, Laura M. Walker, Gunilla B. Karlsson Hedestam
Tags
SARS-CoV-2
vaccination
antibody responses
spike-specific monoclonal antibodies
neutralizing activity
memory B cells
mRNA-1273
Related Publications
Explore these studies to deepen your understanding of the subject.
